• Scientists investigate how psychedelic drugs interact with brain cells at the molecular level

    1 month ago - By News Medical

    Psychedelic drugs such as LSD, psilocybin, and mescaline cause severe and often long-lasting hallucinations, but they show great potential in treating serious psychiatric conditions, such as major depressive disorder.
    Read more ...

     

  • A Scientific First: How Psychedelics Bind to Key Brain Cell Receptor

    1 month ago - By UNC Healthcare

    This work, published in Cell and led by the UNC-Chapel Hill lab of Bryan L. Roth, MD, PhD, sets the stage for the discovery of new kinds of antidepressants, anti-anxiety drugs, and treatments for substance use disorders.
    Read more ...

     

  • A scientific first: How psychedelics bind to key brain cell receptor

    1 month ago - By ScienceDaily

    For the first time, scientists solved the high-resolution structure of these compounds when they are actively bound to the 5-HT2A serotonin receptor on the surface of brain cells. This discovery is already leading to the exploration of more precise compounds that could eliminate hallucinations but still have strong therapeutic effects. Psilocybin - the psychedelic compound in mushrooms - has already been granted breakthrough status by the FDA to treat depression.
    Read more ...